nach oben

Cancer Microenvironment

Erschienen in:

01.12.2012 | Original Article

Molecular Regulation of Lymphangiogenesis in Development and Tumor Microenvironment

verfasst von: Taotao Li, Jianfeng Yang, Quansheng Zhou, Yulong He

Erschienen in: Cancer Microenvironment | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

A rapid progress has been made in the field of lymphatic research during the last 15 years. This includes better understanding of the cellular events and molecular players involved in the lymphatic vessel formation and remodeling in development. The key players identified in developmental lymphangiogenesis, including vascular endothelial cell growth factor-C (VEGF-C) / VEGFR-3 and angiopoietins (ANGPTs)/ TIE pathways, are also crucial for pathological lymphatic vessel growth. In solid tumor, tumor cells as well as tumor-associated stromal cells, such as tumor-infiltrating leukocytes, contribute to intra- and peri-tumoral lymphangiogenesis via secreting lymphangiogenic growth factors. Tumor-associated lymphatic endothelial cells also interact actively with tumor cells and leukocytes via secreting various chemokines. It has been well established that tumor lymphangiogenesis promotes tumor cell dissemination to regional lymph nodes. Thus manipulation of lymphangiogenic microenvironment could become another valuable approach in the combat of tumor progression.

Abtahian F, Guerriero A et al (2003) Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk. Science 299(5604):247–251PubMedCrossRef

Adams RH, Wilkinson GA et al (1999) Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev 13(3):295–306PubMedCrossRef

Albuquerque RJ, Hayashi T et al (2009) Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nat Med 15(9):1023–1030PubMedCrossRef

Alitalo K (2011) The lymphatic vasculature in disease. Nat Med 17(11):1371–1380PubMedCrossRef

Angeli V, Ginhoux F et al (2006) B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 24(2):203–215PubMedCrossRef

Augustin HG, Young Koh G et al (2009) Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 10(3):165–177PubMedCrossRef

Backhed F, Crawford PA et al (2007) Postnatal lymphatic partitioning from the blood vasculature in the small intestine requires fasting-induced adipose factor. Proc Natl Acad Sci USA 104(2):606–611PubMedCrossRef

Baldwin ME, Halford MM et al (2005) Vascular endothelial growth factor D is dispensable for development of the lymphatic system. Mol Cell Biol 25(6):2441–2449PubMedCrossRef

Baluk P, Tammela T et al (2005) Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest 115(2):247–257PubMed

Baluk P, Fuxe J et al (2007) Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med 204(10):2349–2362PubMedCrossRef

Baluk P, Yao LC et al (2009) TNF-alpha drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice. J Clin Invest 119(10):2954–2964PubMed

Bazigou E, Xie S et al (2009) Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis. Dev Cell 17(2):175–186PubMedCrossRef

Beasley NJ, Prevo R et al (2002) Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 62(5):1315–1320PubMed

Bertozzi CC, Schmaier AA et al (2010) Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Blood 116(4):661–670PubMedCrossRef

Bos FL, Caunt M et al (2011) CCBE1 is essential for mammalian lymphatic vascular development and enhances the lymphangiogenic effect of vascular endothelial growth factor-C in vivo. Circ Res 109(5):486–491PubMedCrossRef

Bowles J, Schepers G et al (2000) Phylogeny of the SOX family of developmental transcription factors based on sequence and structural indicators. Dev Biol 227(2):239–255PubMedCrossRef

Carramolino L, Fuentes J et al (2010) Platelets play an essential role in separating the blood and lymphatic vasculatures during embryonic angiogenesis. Circ Res 106(7):1197–1201PubMedCrossRef

Caunt M, Mak J et al (2008) Blocking neuropilin-2 function inhibits tumor cell metastasis. Cancer Cell 13(4):331–342PubMedCrossRef

Chen L, Mupo A et al (2010) Tbx1 regulates Vegfr3 and is required for lymphatic vessel development. J Cell Biol 189(3):417–424PubMedCrossRef

Chen CY, Bertozzi C et al (2012) Blood flow reprograms lymphatic vessels to blood vessels. J Clin Invest 122(6):2006–2017PubMedCrossRef

Clavin NW, Avraham T et al (2008) TGF-beta1 is a negative regulator of lymphatic regeneration during wound repair. Am J Physiol Heart Circ Physiol 295(5):H2113–2127PubMedCrossRef

Condeelis J, Pollard JW (2006) Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124(2):263–266PubMedCrossRef

Cueni LN, Chen L et al (2010) Podoplanin-Fc reduces lymphatic vessel formation in vitro and in vivo and causes disseminated intravascular coagulation when transgenically expressed in the skin. Blood 116(20):4376–4384PubMedCrossRef

Dellinger M, Hunter R et al (2008) Defective remodeling and maturation of the lymphatic vasculature in Angiopoietin-2 deficient mice. Dev Biol 319(2):309–320PubMedCrossRef

Dummler B, Hemmings BA (2007) Physiological roles of PKB/Akt isoforms in development and disease. Biochem Soc Trans 35(Pt 2):231–235PubMed

Dumont DJ, Jussila L et al (1998) Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282(5390):946–949PubMedCrossRef

Fagiani E, Lorentz P et al (2011) Angiopoietin-1 and −2 exert antagonistic functions in tumor angiogenesis, yet both induce lymphangiogenesis. Cancer Res 71(17):5717–5727PubMedCrossRef

Fischer C, Jonckx B et al (2007) Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell 131(3):463–475PubMedCrossRef

Flister MJ, Wilber A et al (2010) Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1. Blood 115(2):418–429PubMedCrossRef

Forster R, Schubel A et al (1999) CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99(1):23–33PubMedCrossRef

Francois M, Caprini A et al (2008) Sox18 induces development of the lymphatic vasculature in mice. Nature 456(7222):643–647PubMedCrossRef

Fu J, Gerhardt H et al (2008) Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice. J Clin Invest 118(11):3725–3737PubMedCrossRef

Fukumura D, Duda DG et al (2010) Tumor microvasculature and microenvironment: novel insights through intravital imaging in pre-clinical models. Microcirculation 17(3):206–225PubMedCrossRef

Gale N, Thurston G et al (2002) Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by angiopoietin-1. Dev Cell 3(3):411PubMedCrossRef

Geudens I, Herpers R et al (2010) Role of delta-like-4/Notch in the formation and wiring of the lymphatic network in zebrafish. Arterioscler Thromb Vasc Biol 30(9):1695–1702PubMedCrossRef

Gjini E, Hekking LH et al (2011) Zebrafish Tie-2 shares a redundant role with Tie-1 in heart development and regulates vessel integrity. Dis Model Mech 4(1):57–66PubMedCrossRef

Gunn MD, Tangemann K et al (1998) A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci USA 95(1):258–263PubMedCrossRef

Hamada K, Oike Y et al (2000) VEGF-C signaling pathways through VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis. Blood 96(12):3793–3800PubMed

Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674PubMedCrossRef

He Y, Kozaki K et al (2002) Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst 94(11):819–825PubMedCrossRef

He Y, Karpanen T et al (2004a) Role of lymphangiogenic factors in tumor metastasis. Biochim Biophys Acta 1654(1):3–12PubMed

He Y, Rajantie I et al (2004b) Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis. Cancer Res 64(11):3737–3740PubMedCrossRef

He Y, Rajantie I et al (2005) Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res 65(11):4739–4746PubMedCrossRef

Hedrick JA, Zlotnik A (1997) Identification and characterization of a novel beta chemokine containing six conserved cysteines. J Immunol 159(4):1589–1593PubMed

Hellstrom M, Kalen M et al (1999) Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126(14):3047–3055PubMed

Hidalgo A, Peired AJ et al (2007) Complete identification of E-selectin ligands on neutrophils reveals distinct functions of PSGL-1, ESL-1, and CD44. Immunity 26(4):477–489PubMedCrossRef

Hirakawa S, Kodama S et al (2005) VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 201(7):1089–1099PubMedCrossRef

Hogan BM, Bos FL et al (2009) Ccbe1 is required for embryonic lymphangiogenesis and venous sprouting. Nat Genet 41(4):396–398PubMedCrossRef

Holopainen T, Huang H et al (2009) Angiopoietin-1 overexpression modulates vascular endothelium to facilitate tumor cell dissemination and metastasis establishment. Cancer Res 69(11):4656–4664PubMedCrossRef

Holopainen T, Saharinen P et al (2012) Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis. J Natl Cancer Inst 104(6):461–475PubMedCrossRef

Hong YK, Harvey N et al (2002) Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev Dyn 225(3):351–357PubMedCrossRef

Horiguchi A, Ito K et al (2008) Intratumoral lymphatics and lymphatic invasion are associated with tumor aggressiveness and poor prognosis in renal cell carcinoma. Urology 71(5):928–932PubMedCrossRef

Hromas R, Kim CH et al (1997) Isolation and characterization of Exodus-2, a novel C-C chemokine with a unique 37-amino acid carboxyl-terminal extension. J Immunol 159(6):2554–2558PubMed

Hu B, Guo P et al (2003) Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2. Proc Natl Acad Sci USA 100(15):8904–8909PubMedCrossRef

Hu B, Jarzynka MJ et al (2006) Angiopoietin 2 induces glioma cell invasion by stimulating matrix metalloprotease 2 expression through the alphavbeta1 integrin and focal adhesion kinase signaling pathway. Cancer Res 66(2):775–783PubMedCrossRef

Ichise H, Ichise T et al (2009) Phospholipase Cgamma2 is necessary for separation of blood and lymphatic vasculature in mice. Development 136(2):191–195PubMedCrossRef

Imanishi Y, Hu B et al (2007) Angiopoietin-2 stimulates breast cancer metastasis through the alpha(5)beta(1) integrin-mediated pathway. Cancer Res 67(9):4254–4263PubMedCrossRef

Imanishi Y, Hu B et al (2011) Angiopoietin-2, an angiogenic regulator, promotes initial growth and survival of breast cancer metastases to the lung through the integrin-linked kinase (ILK)-AKT-B cell lymphoma 2 (Bcl-2) pathway. J Biol Chem 286(33):29249–29260PubMedCrossRef

Irigoyen M, Anso E et al (2007) Hypoxia alters the adhesive properties of lymphatic endothelial cells. A transcriptional and functional study. Biochim Biophys Acta 1773(6):880–890PubMedCrossRef

Irjala H, Johansson EL et al (2001) Mannose receptor is a novel ligand for L-selectin and mediates lymphocyte binding to lymphatic endothelium. J Exp Med 194(8):1033–1042PubMedCrossRef

Issa A, Le TX et al (2009) Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype. Cancer Res 69(1):349–357PubMedCrossRef

Iwata C, Kano MR et al (2007) Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis. Cancer Res 67(21):10181–10189PubMedCrossRef

Jiang S, Bailey AS et al (2008) Hematopoietic stem cells contribute to lymphatic endothelium. PLoS One 3(11):e3812PubMedCrossRef

Johnson LA, Jackson DG (2008) Cell traffic and the lymphatic endothelium. Ann N Y Acad Sci 1131:119–133PubMedCrossRef

Johnson LA, Clasper S et al (2006) An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. J Exp Med 203(12):2763–2777PubMedCrossRef

Jurisic G, Maby-El Hajjami H et al (2012) “An Unexpected Role of Semaphorin3A/Neuropilin-1 Signaling in Lymphatic Vessel Maturation and Valve Formation”. Circ Res 2012 Jun 20. doi:10.1161/CIRCRESAHA.112.269399

Kabashima K, Shiraishi N et al (2007) CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells. Am J Pathol 171(4):1249–1257PubMedCrossRef

Kaipainen A, Korhonen J et al (1995) Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92(8):3566–3570PubMedCrossRef

Kanady JD, Dellinger MT et al (2011) Connexin37 and Connexin43 deficiencies in mice disrupt lymphatic valve development and result in lymphatic disorders including lymphedema and chylothorax. Dev Biol 354(2):253–266PubMedCrossRef

Kang S, Lee SP et al (2009) Toll-like receptor 4 in lymphatic endothelial cells contributes to LPS-induced lymphangiogenesis by chemotactic recruitment of macrophages. Blood 113(11):2605–2613PubMedCrossRef

Karkkainen MJ, Ferrell RE et al (2000) Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet 25(2):153–159PubMedCrossRef

Karkkainen MJ, Saaristo A et al (2001) A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci USA 98(22):12677–12682PubMedCrossRef

Karkkainen MJ, Haiko P et al (2004) Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5(1):74–80PubMedCrossRef

Karpanen T, Egeblad M et al (2001) Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res 61(5):1786–1790PubMed

Karpanen T, Heckman CA et al (2006) Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J 20(9):1462–1472PubMedCrossRef

Kataru RP, Jung K et al (2009) Critical role of CD11b + macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood 113(22):5650–5659PubMedCrossRef

Kataru RP, Kim H et al (2011) T lymphocytes negatively regulate lymph node lymphatic vessel formation. Immunity 34(1):96–107PubMedCrossRef

Kazenwadel J, Secker GA et al (2012) “Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature”. Blood 119(5):1283–1291PubMedCrossRef

Kerjaschki D (2005) The crucial role of macrophages in lymphangiogenesis. J Clin Invest 115(9):2316–2319PubMedCrossRef

Kerjaschki D, Regele HM et al (2004) Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol 15(3):603–612PubMedCrossRef

Kim I, Kim HG et al (2000) Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-Kinase/Akt signal transduction pathway. Circ Res 86(1):24–29PubMedCrossRef

Kim H, Nguyen VP et al (2010a) Embryonic vascular endothelial cells are malleable to reprogramming via Prox1 to a lymphatic gene signature. BMC Dev Biol 10:72PubMedCrossRef

Kim M, Koh YJ et al (2010b) CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche. Cancer Res 70(24):10411–10421PubMedCrossRef

Kim H, Kataru RP et al (2012) Regulation and implications of inflammatory lymphangiogenesis. Trends Immunol 33(7):350–356PubMedCrossRef

Kozaki K, Miyaishi O et al (2000) Establishment and characterization of a human lung cancer cell line NCI- H460-LNM35 with consistent lymphogenous metastasis via both subcutaneous and orthotopic propagation. Cancer Res 60(9):2535–2540PubMed

Kozaki K, Koshikawa K et al (2001) Multi-faceted analyses of a highly metastatic human lung cancer cell line NCI-H460-LNM35 suggest mimicry of inflammatory cells in metastasis. Oncogene 20(31):4228–4234PubMedCrossRef

Kraizer Y, Mawasi N et al (2001) Vascular endothelial growth factor and angiopoietin in liver regeneration. Biochem Biophys Res Commun 287(1):209–215PubMedCrossRef

Krishnan J, Kirkin V et al (2003) Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats. Cancer Res 63(3):713–722PubMed

Kumar SR, Singh J et al (2006) Receptor tyrosine kinase EphB4 is a survival factor in breast cancer. Am J Pathol 169(1):279–293PubMedCrossRef

Lapinski PE, Kwon S et al (2012) “RASA1 maintains the lymphatic vasculature in a quiescent functional state in mice”. J Clin Invest 122(2):733–747

Ledgerwood LG, Lal G et al (2008) The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics. Nat Immunol 9(1):42–53PubMedCrossRef

Lee K, Park do J et al (2010) Increased intratumoral lymphatic vessel density correlates with lymph node metastasis in early gastric carcinoma. Ann Surg Oncol 17(1):73–80PubMedCrossRef

Lin FJ, Chen X et al (2010) Direct transcriptional regulation of neuropilin-2 by COUP-TFII modulates multiple steps in murine lymphatic vessel development. J Clin Invest 120(5):1694–1707PubMedCrossRef

Luther SA, Tang HL et al (2000) Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc Natl Acad Sci USA 97(23):12694–12699PubMedCrossRef

Makinen T, Jussila L et al (2001) Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med 7(2):199–205PubMedCrossRef

Makinen T, Adams RH et al (2005) PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev 19(3):397–410PubMedCrossRef

Mantovani A, Allavena P et al (2008) Cancer-related inflammation. Nature 454(7203):436–444PubMedCrossRef

Maruyama K, Ii M et al (2005) Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 115(9):2363–2372PubMedCrossRef

Miteva DO, Rutkowski JM et al (2010) Transmural flow modulates cell and fluid transport functions of lymphatic endothelium. Circ Res 106(5):920–931PubMedCrossRef

Morisada T, Oike, Y et al (2005) “Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation”. Blood 105(12):4649–4656PubMedCrossRef

Mouta-Bellum C, Kirov A et al (2009) Organ-specific lymphangiectasia, arrested lymphatic sprouting, and maturation defects resulting from gene-targeting of the PI3K regulatory isoforms p85alpha, p55alpha, and p50alpha. Dev Dyn 238(10):2670–2679PubMedCrossRef

Muller A, Homey B et al (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410(6824):50–56PubMedCrossRef

Nagira M, Imai T et al (1997) Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemoattractant for lymphocytes and mapped to chromosome 9p13. J Biol Chem 272(31):19518–19524PubMedCrossRef

Niessen K, Zhang G et al (2010) ALK1 signaling regulates early postnatal lymphatic vessel development. Blood 115(8):1654–1661PubMedCrossRef

Niessen K, Zhang G et al (2011) The Notch1-Dll4 signaling pathway regulates mouse postnatal lymphatic development. Blood 118(7):1989–1997PubMedCrossRef

Nilsson I, Bahram F et al (2010) VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts. EMBO J 29(8):1377–1388PubMedCrossRef

Norrmen C, Ivanov KI et al (2009) FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1. J Cell Biol 185(3):439–457PubMedCrossRef

Norrmen C, Tammela T et al (2011) Biological basis of therapeutic lymphangiogenesis. Circulation 123(12):1335–1351PubMedCrossRef

Oka M, Iwata C et al (2008) Inhibition of endogenous TGF-beta signaling enhances lymphangiogenesis. Blood 111(9):4571–4579PubMedCrossRef

Okazaki T, Ni A et al (2009) alpha5beta1 Integrin blockade inhibits lymphangiogenesis in airway inflammation. Am J Pathol 174(6):2378–2387PubMedCrossRef

Oliver G, Detmar M (2002) The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev 16(7):773–783PubMedCrossRef

Paavonen K, Puolakkainen P et al (2000) Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol 156(5):1499–1504PubMedCrossRef

Padera TP, Kadambi A et al (2002) Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296(5574):1883–1886PubMedCrossRef

Pajusola K, Aprelikova O et al (1992) FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines [published erratum appears in Cancer Res 1993 Aug 15;53(16):3845]. Cancer Res 52(20):5738–5743PubMed

Papapetropoulos A, Fulton D et al (2000) Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J Biol Chem 275(13):9102–9105PubMedCrossRef

Pennisi D, Gardner J et al (2000) Mutations in Sox18 underlie cardiovascular and hair follicle defects in ragged mice. Nat Genet 24(4):434–437PubMedCrossRef

Petrova TV, Makinen T et al (2002) Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J 21(17):4593–4599PubMedCrossRef

Petrova TV, Karpanen T et al (2004) Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat Med 10(9):974–981PubMedCrossRef

Pollard JW (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4(1):71–78PubMedCrossRef

Prevo R, Banerji S et al (2004) Rapid plasma membrane-endosomal trafficking of the lymph node sinus and high endothelial venule scavenger receptor/homing receptor stabilin-1 (FEEL-1/CLEVER-1). J Biol Chem 279(50):52580–52592PubMedCrossRef

Rinderknecht M, Detmar M (2008) Tumor lymphangiogenesis and melanoma metastasis. J Cell Physiol 216(2):347–354PubMedCrossRef

Ristimaki A, Narko K et al (1998) Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem 273(14):8413–8418PubMedCrossRef

Roberts N, Kloos B et al (2006) Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2. Cancer Res 66(5):2650–2657PubMedCrossRef

Ruddell A, Kelly-Spratt KS et al (2008) p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis. Oncogene 27(22):3145–3155PubMedCrossRef

Saban MR, Memet S et al (2004) Visualization of lymphatic vessels through NF-kappaB activity. Blood 104(10):3228–3230PubMedCrossRef

Sabine A, Agalarov Y et al (2012) “Mechanotransduction, PROX1, and FOXC2 cooperate to control connexin37 and calcineurin during lymphatic-valve formation”. Dev Cell 22(2):430–444PubMedCrossRef

Saharinen P, Helotera H et al (2010) Claudin-like protein 24 interacts with the VEGFR-2 and VEGFR-3 pathways and regulates lymphatic vessel development. Genes Dev 24(9):875–880PubMedCrossRef

Salmi M, Koskinen K et al (2004) CLEVER-1 mediates lymphocyte transmigration through vascular and lymphatic endothelium. Blood 104(13):3849–3857PubMedCrossRef

Schepers GE, Teasdale RD et al (2002) Twenty pairs of sox: extent, homology, and nomenclature of the mouse and human sox transcription factor gene families. Dev Cell 3(2):167–170PubMedCrossRef

Schmid-Schonbein GW (1990) Microlymphatics and lymph flow. Physiol Rev 70(4):987–1028PubMed

Schoppmann SF, Birner P et al (2001) “Lymphatic microvessel density and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer.”. Anticancer Res 21(4A):2351–2355PubMed

Schulz P, Fischer C et al (2011) Angiopoietin-2 drives lymphatic metastasis of pancreatic cancer. FASEB J 25(10):3325–3335PubMedCrossRef

Schwab SR, Cyster JG (2007) Finding a way out: lymphocyte egress from lymphoid organs. Nat Immunol 8(12):1295–1301PubMedCrossRef

Shields JD, Kourtis IC et al (2010) Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. Science 328(5979):749–752PubMedCrossRef

Shimoda H, Bernas MJ et al (2007) Abnormal recruitment of periendothelial cells to lymphatic capillaries in digestive organs of angiopoietin-2-deficient mice. Cell Tissue Res 328(2):329–337PubMedCrossRef

Shiojima I, Walsh K (2006) Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev 20(24):3347–3365PubMedCrossRef

Shrestha B, Hashiguchi T et al (2010) B cell-derived vascular endothelial growth factor A promotes lymphangiogenesis and high endothelial venule expansion in lymph nodes. J Immunol 184(9):4819–4826PubMedCrossRef

Srinivasan RS, Geng X et al (2010) The nuclear hormone receptor Coup-TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells. Genes Dev 24(7):696–707PubMedCrossRef

Stacker SA, Baldwin ME et al (2002) The role of tumor lymphangiogenesis in metastatic spread. FASEB J 16(9):922–934PubMedCrossRef

Straume O, Jackson DG et al (2003) Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin Cancer Res 9(1):250–256PubMed

Suri C, Jones PF et al (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87(7):1171–1180PubMedCrossRef

Suzuki-Inoue K, Inoue O et al (2010) “Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets”. J Biol Chem 285(32):24494–24507PubMedCrossRef

Swartz MA, Kaipainen A et al (1999) Mechanics of interstitial-lymphatic fluid transport: theoretical foundation and experimental validation. J Biomech 32(12):1297–1307PubMedCrossRef

Tammela T, Saaristo A et al (2005) Angiopoietin-1 promotes lymphatic sprouting and hyperplasia. Blood 105(12):4642–4648PubMedCrossRef

Tammela T, Zarkada G et al (2008) Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 454(7204):656–660PubMedCrossRef

Taniguchi K, Kohno R et al (2007) Spreds are essential for embryonic lymphangiogenesis by regulating vascular endothelial growth factor receptor 3 signaling. Mol Cell Biol 27(12):4541–4550PubMedCrossRef

Uhrin P, Zaujec J et al (2010) “Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation”. Blood 115(19):3997–4005PubMedCrossRef

Van den Eynden GG, Vandenberghe MK et al (2007) Increased sentinel lymph node lymphangiogenesis is associated with nonsentinel axillary lymph node involvement in breast cancer patients with a positive sentinel node. Clin Cancer Res 13(18 Pt 1):5391–5397PubMedCrossRef

Wang Y, Oliver G (2010) Current views on the function of the lymphatic vasculature in health and disease. Genes Dev 24(19):2115–2126PubMedCrossRef

Wang HU, Chen ZF et al (1998) Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93(5):741–753PubMedCrossRef

Wang Y, Nakayama M et al (2010) Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 465(7297):483–486PubMedCrossRef

Wegner M (1999) From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res 27(6):1409–1420PubMedCrossRef

Wigle JT, Oliver G (1999) Prox1 function is required for the development of the murine lymphatic system. Cell 98(6):769–778PubMedCrossRef

Wigle JT, Chowdhury K et al (1999) Prox1 function is crucial for mouse lens-fibre elongation. Nat Genet 21(3):318–322PubMedCrossRef

Wigle JT, Harvey N et al (2002) An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 21(7):1505–1513PubMedCrossRef

Wiley HE, Gonzalez EB et al (2001) Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J Natl Cancer Inst 93(21):1638–1643PubMedCrossRef

Willis RA (1973) The spread of tumours in the human body. Butterworths, London

Wyble CW, Hynes KL et al (1997) TNF-alpha and IL-1 upregulate membrane-bound and soluble E-selectin through a common pathway. J Surg Res 73(2):107–112PubMedCrossRef

Xu Y, Yuan L et al (2010) Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3. J Cell Biol 188(1):115–130PubMedCrossRef

Yuan L, Moyon D et al (2002) Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 129(20):4797–4806PubMed

Zhang X, Groopman JE et al (2005) Extracellular matrix regulates endothelial functions through interaction of VEGFR-3 and integrin alpha5beta1. J Cell Physiol 202(1):205–214PubMedCrossRef

Zhang L, Zhou F et al (2010) VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis. Cell Res 20(12):1319–1331PubMedCrossRef

Zhou F, Chang Z et al (2010) Akt/Protein kinase B is required for lymphatic network formation, remodeling, and valve development. Am J Pathol 177(4):2124–2133PubMedCrossRef

Zumsteg A, Baeriswyl V et al (2009) Myeloid cells contribute to tumor lymphangiogenesis. PLoS One 4(9):e7067PubMedCrossRef

Titel: Molecular Regulation of Lymphangiogenesis in Development and Tumor Microenvironment
verfasst von: Taotao Li
Jianfeng Yang
Quansheng Zhou
Yulong He
Publikationsdatum: 01.12.2012
Verlag: Springer Netherlands
Erschienen in: Cancer Microenvironment / Ausgabe 3/2012
Print ISSN: 1875-2292
Elektronische ISSN: 1875-2284
DOI: https://doi.org/10.1007/s12307-012-0119-6

Neu im Fachgebiet Onkologie

24.04.2024 | DGIM 2024 | Nachrichten

Springer Medizin

Molecular Regulation of Lymphangiogenesis in Development and Tumor Microenvironment

Abstract

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2012

TNFSF15 Modulates Neovascularization and Inflammation

The Plexiform Neurofibroma Microenvironment

Deciphering the Key Features of Malignant Tumor Microenvironment for Anti-cancer Therapy

Cancer Microenvironment and Cancer Vaccine

Introduction: A Special Issue on Tumor Microenvironment Research in China and Asia

Role of Bone Marrow-Derived Cells in Angiogenesis: Focus on Macrophages and Pericytes

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie